Puma Biotechnology Inc reports results for the quarter ended in December - Earnings Summary

Puma Biotechnology

02/03/2023 22:02

* Puma Biotechnology Inc  PBYI.OQ  reported a quarterly
adjusted
loss of 12 cents​​ per share for the quarter ended in December.
The mean expectation of four analysts for the quarter was
for earnings of 5 cents per share.
    * Revenue rose 18.6% to $65.70 million from a year ago;
analysts
expected $57.06 million. 
    * Puma Biotechnology Inc's reported EPS for the quarter was
a loss
of 12 cents​.
    * The mean earnings estimate of analysts had fallen by
about 9.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Puma Biotechnology Inc shares had fallen by 5.0% this
quarter.
    * The company reported a quarterly loss of $5.6 million.
    * Wall Street's median 12-month price target for Puma
Biotechnology Inc is $4.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 2
at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.05           -0.12          Missed
 Sep. 30 2022      -0.05          -0.01          Beat
 Jun. 30 2022      0.01           0.21           Beat
 Mar. 31 2022      -0.17          -0.08          Beat